Speaker Biographies

A Global Medical Device Leader and Patient Safety Advocate, Doug has served in leadership marketing and business development roles at Covidien, Medtronic and BD. He currently serves as Senior Vice President at Solventum. Doug is a survivor of a home accident involving a chainsaw that led to a lengthy recovery time and ongoing PTSD frequently triggered by encountering rooms, lights, and sounds associated with the incident.

Dr. Renae Beaumont is an award-winning clinical psychologist who is the founder of the online gaming-based therapy program Secret Agent Society (SAS). Originally from Australia, Dr. Beaumont moved to the US nine years ago, and is currently a faculty member and clinician at Weill Cornell Medicine, New York Presbyterian Hospital. Dr. Beaumont is passionate about using technologically innovative approaches to improve the mental health and wellbeing of youth and families. Her research has examined the feasibility, acceptability and effectiveness of wearables, virtual reality, artificial intelligence and therapeutic apps and platforms to assess and treat psychiatric conditions.

Andreas Caduff has been a driving force in the development of non-invasive and contextualized physiological monitoring. He was serving as CTO of Solianis where he orchestrated the development of non-invasive glucose monitoring. He then founded Biovotion and served for 7 years as CEO, offering a state-of-the-art user-centric, analytics driven ecosystem, powered by medical wearable technology. Biovotion received several international awards and high calibre endorsements for its innovations, including an award from the XPrize Foundation. Biovotion was acquired in 2019. Today he is a healthtech leader at Amazon, working at the interface of medical technology, physiological monitoring and data science, towards a more holistic view of health

Dr. Jenna Carl, Ph.D., is Chief Medical Officer at Big Health, where she advances the company’s clinical, regulatory, & reimbursement strategies and industry-leading body of clinical evidence that validates the safety and efficacy of its digital mental health programs for insomnia, anxiety, and depression. Responsible for a team of clinicians, researchers, medical affairs, policy, and regulatory experts, Dr. Carl leads Big Health’s development of digital programs for high prevalence, poorly treated mental health conditions. In August 2024, she obtained FDA clearances for SleepioRx and DaylightRx, digital treatments for insomnia and generalized anxiety disorder, respectively. She was also the clinical architect for DaylightRx. A practicing clinical psychologist and researcher who specializes in anxiety, depression, insomnia, and related mental health disorders, she has developed multiple novel cognitive behavioral treatments (CBT), including both in-person and digital treatments. Dr. Carl has authored over 35 peer-reviewed publications, and has presented her research at leading international and national conferences. She previously served as Chair of the APA’s Division 12 Presidential Task Force on the integration of technology and mental health treatment. Dr. Carl obtained her doctorate in clinical psychology from Boston University. She trained at the Center for Anxiety and Related Disorders at Boston University; Massachusetts General Hospital; Harvard Medical School; and the VA Health System’s National Center for Innovation to Implementation.

Dr. Cho is a behavior scientist and clinical epidemiologist specializing in the psycho-social impacts of cancer and its treatment, as well as the development of patient-reported outcome measures (PROMs). She serves as Chair of the Department of Clinical Research Design and Evaluation at the Samsung Advanced Institute for Health Sciences & Technology (SAIHST), Sungkyunkwan University, Seoul, Korea. In her role as Director of the Center for Clinical Epidemiology and the Cancer Education Center at Samsung Medical Center, Dr. Cho leads initiatives that integrate digital health solutions and PROMs to address the needs of cancer patients and their families. An expert in digital therapeutics, Dr. Cho is a consulting committee member for the Digital Therapeutics Clinical Evaluation Standards Expert Committee under the Korean Ministry of Food and Drug Safety (MFDS). She actively collaborates with the MFDS to establish clinical evaluation standards and regulatory frameworks that accelerate the development of digital health solutions. Her research includes advancing digital biomarkers, addressing social isolation and loneliness, and developing AI-based platforms to support single-person households and vulnerable populations.

Dr. Ciara Clancy is the founder of Beats Medical, a pioneering company delivering digital assessments and therapies for CNS and rare diseases. A physiotherapist with a PhD in Neurosurgery Outcomes, Ciara founded Beats Medical to transform evidence generation and post-market surveillance, digitizing gold-standard drug trial assessments and allied health therapy programs to drive unparalleled sensitivity, engagement, and retention. Beats Medical has partnered with Top 10 Pharma companies in multi-disease deployments and achieved world-first private and public reimbursements for digital therapeutics worldwide. Ciara’s contributions to healthcare innovation have been recognized by awards from Google, Cartier, the European Commission, EY, and Forbes 30 Under 30, and she has held key board positions, including within leading European Data Analytics Centers and Healthcare Transformation steering groups.

Edward Cox is an innovative, inspiring, and relentless life science and digital health executive. With a background in executive leadership, pharma, tech, investment banking and public markets, he is uniquely positioned to lead digital health through fundraising, strategic partnering, FDA approval and exit.

Alyssa is Head of US Clinical Strategy at ieso. She works cross-functionally to envision, plan, and bring solutions that prioritize patients’ needs to the US market. A clinical psychologist by training, she began her career as a professor where she balanced treating patients, teaching courses, training therapists, and conducting research on the intersection of mental health and digital interventions. She has worked in a wide range of clinical settings including private practice, residential treatment, university-based behavioral health, Veterans Affairs, community clinics, and academic medical centers. Looking to make a stronger impact by connecting treatments that work to the people who need them, she transitioned to industry first at Pear Therapeutics and then Twill (Happify) holding roles across medical affairs, corporate strategy, and clinical strategy.

I'm dedicating this chapter of my life to one mission: Helping millions manage their disease in the best way possible. At Alex Therapeutics, we combine psychology, technology, and design to empower people to live longer, healthier and happier lives. We partner with pharma to quickly launch and scale therapy and drug app companions.

Jay is the General Partner at Wavemaker Three-Sixty Health, a Los Angeles-based venture fund 100% focused on health-tech startups seeking Seed and Series A investment. The fund has 400 Limited Partners, the vast majority of whom are healthcare organizations or healthcare executives, giving the fund a true super-power when it comes to sourcing, evaluating, and especially providing commercial support to the early stage companies in which it invests. Before becoming a venture capitalist, Jay Goss helped bring companies, a lot of them, to life…30+ all in. And in so doing, learned the entrepreneurial journey extremely well.

Senior Conference Director at Cambridge Innovation Institute and Co-Founder of The DTx Series.

Brian Harris is the Co-Founder and CEO of MedRhythms; a company focused on the intersection music, neuroscience and technology. Brian is a board-certified music therapist and one of 350 Neurologic Music Therapist Fellows in the world. Brian’s clinical work is focused at Spaulding Rehabilitation Hospital, where he created and implemented their first inpatient full time Neurologic Music Therapy program, specializing in Traumatic Brain Injury, Stroke, and neurologic disease and built this program to be the most comprehensive NMT program in the country. Brian is also the Co-Founder of the Arts & Neuroscience group at the American Congress of Rehabilitation Medicine. He has been an invited speaker at venues throughout the world including: Harvard Medical School, The Metropolitan Museum of Art, the American Congress of Rehabilitation Medicine, Stanford University, Berklee College of Music, and the Neurology Foundation of India. Brian is an author on multiple publications related to music and rehabilitation and is listed as an inventor on several patents related to MedRhythms products. His work has also been featured in Forbes, CNBC, Rolling Stone, and The Huffington Post. Brian has been named to MedTech Boston's 40 Under 40 Healthcare Innovators and Top 100 Innovation CEOs by World Biz Magazine.

Healthcare innovation is Neil’s driving passion. Drawing on his training as a physician and scientist, Neil has spent his career leading, advising, and investing in the medical and biotech industries. His experience spans established, market-leading corporations to groundbreaking, early-stage start-ups. Neil holds degrees from Duke University, Harvard Medical School, and Oxford University, where he studied as a Rhodes Scholar.

Chris Hemphill believes the right decisions in data science and AI can help serve & uplift those who society neglects. As Senior Director of Commercial Intelligence at Woebot Health, Chris uncovers deep insights about human suffering and support through blended quantitative and qualitative methods. Chris has lead efforts combining health equity and AI to mitigate bias from healthcare algorithms, and this work is recognized by institutions like Chicago Booth’s Center for Applied AI and NYU’s McSilver Institute for Poverty Policy Research. Chris stresses that this work isn’t just about algorithms, it’s about the people and financial structures around them. Outside of Woebot, they currently serve as the NYU McSilver Fellow for Healthcare AI & Health Equity and as a judge for Greystone’s Healthcare Internet Hall of Fame. When not doing this work, Chris loves synthesizers, running, and spicy seafood!

David is a veteran of both the digital therapeutic and video game industries. He has deep experience delivering powerful, scalable platforms demanding industries at very large scale, including as Sr. Software Architect of the Sony PlayStation Network. Within the field of digital therapeutics, Mr. Keene co-founded Dthera Sciences, a company that produced a Digital Therapeutic for Alzheimer's Disease. At Pfizer, he is leading the technical teams building the next generation of Digital Health and Medicine products.

Dr. Shaheen Lakhan, MD, PhD, FAAN, is a pioneering physician-scientist, biopharma board director, and biotech executive with 20 years of experience. Board-certified in neurology and pain medicine, he trained at Cleveland Clinic and Massachusetts General Hospital, driving innovation in therapeutics. As Chief Medical Officer at Click Therapeutics and a Board Director at Frenelle Pharma, he advances cutting-edge treatments. A distinguished academic and philanthropist, he has received prestigious awards, shaped medical education, and contributed over 100 peer-reviewed publications to neuroscience and medicine.

Ashutosh is a passionate and strategic leader with over a decade of experience in the health-tech sector, specializing in developing and executing digital health strategies, forging impactful partnerships, and driving innovation. Currently serving as the Director of Digital Health Strategy & Partnerships at Daiichi Sankyo Europe, a global leader in pharmaceuticals, he is dedicated to advancing healthcare through innovative digital solutions. His work focuses on reducing healthcare costs and improving patient outcomes, all while sustaining current success and driving future business growth.

A former Department of Defense Navy contractor, Camille manages Freespira’s federal sales operations and ongoing engagement with federal accounts. Before devoting her career to helping medical device companies scale their government accounts, Camille spent over 12 years working with the federal government and collaborating closely with veterans and active military personnel organizations.

Siva is the President and Co-Founder of JOGO Health, a digital therapeutics company that uses wearable biosensors and software to treat stroke, chronic pain, and neuromuscular conditions by leveraging the foundational science of neuroplasticity. Siva has over 25 years of experience in healthcare, contributing to the launches of blockbuster drugs such as Botox, Lyrica, and Viagra. His previous venture, an AI-based platform for detecting medication and vaccine side effects, was acquired by IQVIA, the world’s leading clinical research organization with over 80,000 employees and a $40 billion market cap. At IQVIA, he served as General Manager for six years. His invention is now used by companies like Pfizer and Moderna to monitor vaccine side effects. Siva was also credited with discovering a significant security vulnerability during the early days of the internet, which led to major changes in how people securely access websites from public computers. Siva holds three U.S. patents in AI for healthcare and has spoken in over 20 countries on the topic of digital therapeutics and AI in healthcare.

The only female Family Life Chaplain serving on Active Duty in the U.S. Army, in the specific capacity as a Family Life Chaplain, Lisa has provided compassionate care to Soldiers globally, including tours of duty in Kuwait, Iraq and Europe; in addition to being a care provider, Lisa also has suffered from PTSD as a result of her service and continues to faithfully engage any unhelpful triggers in effort to combat for her own wellness as she continues to advocate for the military community at large.

Acacia Parks (PhD, MBA) is a digital health executive whose experience revolves around scientific, product, and regulatory strategy for digital therapeutics/software as medical device (SAMD). As Chief Science Officer of Twill (fka Happify) for 10 years, she built evidence generation strategies for direct-to-consumer, enterprise, health care, Pharma, and FDA audiences. She then spent a year as Chief Behavioral Health Officer at Found, a telemedicine weight loss company, building their behavior change program, both digital product and coaching offerings. Now, she runs Liquid Amber, which delivers strategic advising to DTx and Pharma companies, as well as investors, with a focus on products with high scientific and regulatory complexity, including combined hardware/software packages, novel mechanisms of action and delivery methods, and combination drug/DTx products across a variety of therapeutic areas (including cancer, obesity, myopia, treatment-resistant depression, Alzheimer's, social anxiety, ADHD, and chronic disease).

Amid the demand for effective and accessible healthcare solutions, Joe Perekupka stands at the forefront. As the CEO of Freespira, Inc., Joe is passionate about creating equitable access to care for mental health patients nationwide. He is on a mission to change the treatment paradigm for mental health, having seen firsthand the debilitating effects these disorders have on individuals and their families. Joe is a proven healthcare leader with over 25 years of commercial experience in multiple leadership and functional medical device and digital health roles. He has spent more than a decade commercializing novel technologies with startup and small growth companies focused on the neuroscience market. His prior time as Senior Vice President of North America at Brainsway showcased his instrumental role in the launch of the U.S. subsidiary, consistent revenue growth, and the successful completion of a U.S. initial public offering in 2019. Throughout his tenure in the behavioral health market, Joe has been committed to enhancing mental health solutions via advanced, non-invasive techniques. Joe's contributions extend beyond the boundaries of individual companies. He plays an active role with organizations such as the Digital Therapeutics Alliance, where he maintains co-chair roles that are focused on propelling the DTx industry growth.

David Rawlins is COO of Mynd Immersive, the leading immersive therapeutic platform for SeniorCare, and general partner at HWS Capital an early-stage venture fund focused on digital health. Prior to Mynd Mr. Rawlins co-founded and was COO at MedAvail Technologies, a pharmacy technology company that went public on NASDAQ in 2020. He previously spent nearly 20years in healthcare investment and finance roles with Redmile Group and Morgan Stanley. He has an MA in Neuroscience and Psychology from the University of Oxford.

I have been working for Kaiser Permanente since 2017 and serve as a clinical psychiatrist, director of research, methodologist for our national guidelines council and a consultant for our digital health portfolio. I believe digital therapeutics are a crucial part of the future of psychiatry and adequately meeting population needs with a growing deficit of providers in my field nationwide and worldwide. As a publishing researcher for over 20 years I am excited to both participate in growing the literature around digital therapeutics and to see the field evolving into more active participation in evidence based medicine.

Tifanie is a registered nurse and biologist with specialty certifications in wound and ostomy care. Over the past 15 years, she has worked in a variety of health care settings, spending the majority of her career educating fellow nursing and ancillary staff on pressure injury prevention, product selection and cost efficiency with wound and ostomy related issues. She has worked in multiple hospitals and wound centers on the east coast and as a travel nurse on both the east and west coast. Currently, Tifanie is working in her favorite setting, home health, spearheading a telehealth wound and ostomy program providing clinician to clinician consults in the patient home bringing remote expert wound care to patients in three states. Tifanie provides lectures to local colleges and universities, and community outreach education on these topics. She has presented her work at multiple national conferences highlighting the value of home health wound experts related to improved patient outcomes. While she has always worked to advocate for best patient care, Tifanie considers herself a Nurse & Caregiver Advocate first and foremost and hopes to assist all caregivers in improving their confidence on skin related issues

Dr. Geoffrey Tso leads Health AI at Samsung Research America and is dedicated to scaling personalized health care through the research and implementation of generative AI technologies, including large language models. An internal medicine physician with a research background in medical informatics, Dr. Tso holds a degree in Electrical Engineering and Computer Science from UC Berkeley. He also serves as a Clinical Assistant Professor in Primary Care and Population Health at Stanford University School of Medicine and previously led Clinical Innovation at Curai Health. His expertise encompasses clinical decision support systems, knowledge systems, interoperability, telehealth, and digital health initiatives, all aimed at enhancing healthcare accessibility and providing evidence-based, tailored care to patients.

Paul is the Global Head of Smart & Digital Devices at Roche/Genentech. Paul has 25+ years of experience in medical device R&D, strategic marketing, product management, clinical research, and medical informatics. Prior to Roche/Genentech, he was with Becton Dickinson (BD), as Worldwide Director of Strategic Marketing in their Pharmaceutical Systems business. He was also the head of Product at WellDoc, Inc., where he led the product management activities for WellDoc’s portfolio of mobile health solutions. Paul holds four issued patents in medical software and drug delivery devices and has multiple patent applications. He is also an author of numerous peer-reviewed articles in medical informatics and diabetes. His education includes undergraduate studies in cognitive science and graduate work in health informatics and finance at the University of Minnesota and New York University.

As Dario’s SVP of Strategy & Growth, Chris is leading the effort to bring Dario’s digital health platform to the pharmaceutical and healthcare industries. Recently, he served as a Board Member of the Digital Therapeutics Alliance (DTA), and he has also served as a board member of QualcommLife. He has been a digital health advisor to AT&T, Verizon, Vodafone, Telefonica, Qualcomm, Intel, as well as leading healthcare providers like Mayo Clinic, Cleveland Clinic, Kaiser Permanente, and large employers like Microsoft, Google and Amazon, and MedTech and pharmaceutical companies like Medtronic, Boston Scientific, BD Medical, Eli Lilly, Novartis, Biogen, Sanofi, Merck, Amgen, AstraZeneca, and others. In addition, he was a professor at the University of Utah and served as Executive Director of the Sorenson Center for Discovery & Innovation, a digital therapeutic game incubator. He is the co-author of two books on innovation, creativity, and leadership: Tension—The Energy of Innovation and Solving for Why—Change Your Identity, Change Your Future. He is a highly sought-after speaker, speaking at over 30 events yearly. He is the named inventor on 12 issued patents, has been a founding leader in 10 startups, and has held leadership positions at JP Morgan and PwC. He holds a doctorate from George Washington University in Human and Organizational Learning, an M.B.A. from UCLA Anderson School, a BS in Accounting, and a BA in Asian Studies from Brigham Young University. Chris’s passion is bringing technology to healthcare and patients in a way to deliver experiences that rival the best of Apple, Amazon, Alphabet, and Facebook; to engage consumers/patients in experiences and behaviors that empower them to take control of their health and improve their clinical outcomes, quality of life, wellbeing, while increasing access to care at lower costs.

As Vice President of TeleAcute and Respiratory Care, Cindy is responsible for oversight of the development, implementation and evaluation of telemedicine via the TeleICU, Central Telemetry Center for IL and Virtual Patient Advocate (telesitter) programs for Advocate Health Midwest Region. She is oversees the strategic growth of the Respiratory Care service line. She holds a BSN and MBA from Lewis University, is a fellow for the American College of Healthcare Executives and a member of multiple professional organizations.

Tiffany Yu is a Principal at 7wireVentures, a healthcare venture fund focused on digital health and tech-enabled healthcare services. Prior to 7wire, Tiffany was a Senior Director at Redesign Health where she led three new company launches in healthcare. Tiffany also has experience in growth equity/private equity investments in healthcare IT and services and began her career at F-Prime Capital.